Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Omega Healthcare Investors (OHI)

Omega Healthcare Q4 net income rises to $116 million; 2025 AFFO guidance $2.90-$2.98

Positive Impact 3 of 5 earnings Written later

Omega Healthcare Investors reported fourth-quarter and full-year 2024 results, with Q4 net income of $116 million, or $0.41 per share, up from $57 million, or $0.22 per share, a year earlier. The company also issued 2025 Adjusted FFO guidance of $2.90 to $2.98 per diluted share, which gives shareholders a reference point for the year ahead.

Key points

  • Q4 2024 net income was $116 million, or $0.41 per share, versus $57 million, or $0.22 per share, in Q4 2023.
  • Q4 2024 Adjusted FFO was $214 million, or $0.74 per share, versus $173 million, or $0.68 per share, in Q4 2023.
  • Q4 2024 total revenues were $279.3 million, a $40.0 million increase over Q4 2023.
  • The board declared a $0.67 quarterly dividend on January 29, 2025, payable February 18, 2025, to holders of record on February 10, 2025.

The filing

CompanyOmega Healthcare Investors (OHI)
Form8-K, current report
Filed with the SECFeb 5, 2025, 4:18 PM ET
Accession number0000888491-25-000003

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:11 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 05, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.